Frederick Behringer JR. in Ocala, Florida

Home Florida Ocala

Frederick Behringer JR. has Dermatology as his primary medical specialty. Their primary office is: 2611 Se 17th St in Ocala, Florida.

They're a part of the: Suncoast Skin Solutions medical group which has around 60 members. You can call their office at 813-321-1786 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Duke University School Of Medicine and graduated in 1971 (around 54 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Frederick R Behringer JR. Office Phone and Directions

Frederick Behringer JR.
Suncoast Skin Solutions
2611 Se 17th St
Ocala, Florida 34471
813-321-1786

Patient Ratings
Please rate your experience with Frederick Behringer JR. below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 813-321-1786

Enter a starting address:

Healthcare Info for Frederick Behringer JR.

Medical School: Duke University School Of Medicine
Graduation Year: 1971
The Primary Medical Specialty for Frederick Behringer JR. is listed as: Dermatology
Approximate Years of Experience: 54
PAC (PECOS ID)#: 3577758457
NPI #: 1043218860
NPI Created On: 07/14/2005
NPI Last Updated Listed as: 03/26/2019
Primary Taxonomy Code: 207ND0101X
License Number:
ME0036163
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Tangential biopsy of single skin lesion
Tangential biopsy of additional skin lesion
Punch biopsy of single skin lesion
Removal of growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs
Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs
Removal of malignant growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs
Removal of malignant growth (1.1 to 2.0 centimeters) of the scalp, neck, hands, feet, or genitals
Injection of up to 7 skin growths
Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs
Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth
Repair of wound (5.1 to 7.5 centimeters) of face, ears, eyelids, nose, lips, and/or mouth
Destruction of skin growth
Destruction of 2-14 skin growths
Destruction of 15 or more skin growths
Destruction of up to 14 skin growths
Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs
Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks)
Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals
Biopsy of ear
New patient office or other outpatient visit, typically 10 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794024171

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: SKYRIZI

Open Associated Drug #1: 0074-2042-02

Payments Total: $20

Number of Payments:: 1